Laquinimod reduces neuroaxonal injury through inhibiting microglial activation. - Wikidata - awgldk - TriplyDB

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

http://www.wikidata.org/entity/Q34286754

about

Laquinimod in the treatment of multiple sclerosis: a review of the data so far Remyelination Therapy in Multiple Sclerosis Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease.NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications Progressive multiple sclerosis: from pathogenic mechanisms to treatment.Primary Progressive Multiple Sclerosis: Putting Together the Puzzle Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS Laquinimod treatment in the R6/2 mouse model.1,25-Dihydroxyvitamin D3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis.MP Resulting in Autophagic Cell Death of Microglia through Zinc Changes against Spinal Cord Injury Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells.Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression.Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.Immunosenescence of microglia and macrophages: impact on the ageing central nervous system.Endogenous repair and development inspired therapy of neurodegeneration in progressive multiple sclerosis.Dendritic cells as therapeutic targets in neuroinflammation.The future of multiple sclerosis treatments.Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.Myeloid cells - targets of medication in multiple sclerosis.Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.Laquinimod prevents cuprizone-induced demyelination independent of Toll-like receptor signaling Apolipoprotein E knockout induced inflammatory responses related to microglia in neonatal mice brain via astrocytes.Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.Laquinimod attenuates inflammation by modulating macrophage functions in traumatic brain injury mouse model.Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions.Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.Potential immunotherapies for traumatic brain and spinal cord injury.

P2860

Q26752895-8411844E-5E70-40B7-8DFF-29EDC88F08D4 Q26772359-32C65871-E2DC-4D26-AEA2-A5E6335D4FF5 Q27316866-907D084C-A0EB-4EE4-BA1D-EE73278A53DD Q28078299-F5A0964B-B424-4FB0-9C62-A902BA9D461B Q31139925-21C92C9B-EAE1-4014-A4AE-E01806B916D9 Q33365606-C5E8E26E-F279-4558-93FD-4726216E426A Q33808285-698F702C-F77C-42DA-BD3F-7607C5B5525C Q33890346-E02AE1DA-6690-4C69-86EB-83B317C26313 Q35872062-80052071-E8CF-455E-9A20-0B141BD26F4F Q36530866-EAEDDCF9-CF84-44ED-8108-C77C335FB599 Q37169655-625B262A-A397-4CD9-8D63-E4B6BF00621C Q37274895-6CBD3140-D3AF-42EA-812D-D3AA5A766018 Q37346761-7A61F971-CC6A-4E80-A098-A71B3BF9CEF9 Q38639337-1D5FCD53-D619-4D96-9BE9-43C806A85DCB Q38749164-EF16540E-C5DA-473D-B1FB-48AA6FAEFD6E Q38765008-309D7DA5-59B4-4CFB-ABEE-97E4979218DD Q38771884-EA744BDD-B215-4456-B343-6E9D3CB7728E Q38808485-B32C56A9-AF4F-4D28-B5F7-1B7E8D1463DB Q38837294-79B88166-B29E-4A4B-A4B7-0ACBF1F13D44 Q38924828-6BB4D3BE-A714-49BB-A415-CD5D70B9C229 Q39179797-257E0B44-948E-450E-985B-8EB2705E9488 Q41845688-EAC42BFF-AF45-4C47-BC07-8CF9B8C3B9E2 Q43185058-DB2A1B3A-44BF-4D8E-86E3-DEE5D45A30C5 Q47211013-049E356B-DB83-49B1-84EE-9C1A850E428D Q47695368-F32ADD94-0ECE-462F-A1F8-D5DF2C8E6B11 Q52668328-B8706A80-7874-4CD2-B129-992A61F5B798 Q55428811-F0E41B4D-21F2-4912-863E-17A63C630250 Q55505620-CA77F975-4B3E-45DF-ACF4-4CE514F5A2D8

P2860

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

http://www.wikidata.org/entity/Q34286754

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

@ast

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

@en

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

@nl

type

label

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

@ast

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

@en

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

@nl

prefLabel

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

@ast

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

@en

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

@nl

P1433

Q34286754-4938CAC8-AF4C-40AB-A4F7-A265E56FEA15

P1476

Q34286754-29D7D3CF-4010-47C5-A3F7-C91715CBC1FC

P2093

Q34286754-1C2D282C-4637-43FA-8C5D-6681FDC86072

Q34286754-25B29FA2-4B3D-480B-8525-82F05E4C5950

Q34286754-3A56EE17-7645-491C-8ECD-ACDED43FB154

Q34286754-9761F5AF-7F82-4A39-9C08-AE459A9608BD

Q34286754-C00493F0-7B84-4C0B-B277-BED46FD40538

Q34286754-F01AAB80-8878-4E00-8F71-D63743BBB4FB

Q34286754-F320EFB5-118D-4B28-8A61-A0E41E40E510

P2860

Q34286754-0791A7CF-E9EA-46B8-89BB-69A526A0A870

Q34286754-07BB91C8-DE46-4DDB-BA6D-D6ADB36FC73F

Q34286754-0E7CDB57-4AB8-40C9-8821-627949D4744D

Q34286754-14A696AD-7C33-4F4A-B367-0CE2C49DCFF0

Q34286754-169A9F4A-4E5A-4294-B8BB-F3620012120C

Q34286754-21057ECC-6519-4EEF-8462-17EAA6470D83

Q34286754-21DBA326-0EC4-46BA-9A11-0C1641973CAD

Q34286754-334B9BA4-C306-452E-B057-D457C19CFE64

Q34286754-36BC5AE4-3DFD-4324-B10A-CB70F494951A

Q34286754-65515211-5F74-4A4F-830A-BA8246E6AD31

P304

Q34286754-B0813366-E826-4A46-9833-6AB4270E2CBF

P31

Q34286754-9E07AAB5-AD91-4C01-8415-9E119743E999

P356

Q34286754-B9ACBCA7-FCCC-4D93-941E-F39683B26099

P433

Q34286754-F8168B15-0636-41DC-A6AD-A50A142B0F50

P478

Q34286754-1A45D55C-CB93-4EC5-8DFD-02F0A4A4253B

P50

Q34286754-503278C5-4196-4474-8D51-D13A646F2C55

Q34286754-52DB2C1B-3036-4AD7-9D87-8875BF871E71

P577

Q34286754-C4694A0E-E0B3-4FC6-87C8-8A13E8F2334D

P5875

Q34286754-7310850F-C829-4683-BA6F-D9C6930F1B61

P698

Q34286754-33138249-DE90-4A13-A461-E497E000304E

P921

Q34286754-78444234-1fbe-4d2b-a24e-778b190f438e

Q34286754-B2B6E444-2A5F-4835-BFCB-C2242E89F0C0

P932

Q34286754-BF3045F8-7BEC-46DD-A98F-5EEAA0DBFC13

P356

P1433

Annals of clinical and translational neurology

P1476

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation

@en

P2093

Claudia Silva

http://www.w3.org/2001/XMLSchema#string

Janet Wang

http://www.w3.org/2001/XMLSchema#string

Liat Hayardeny

http://www.w3.org/2001/XMLSchema#string

Michael B Keough

http://www.w3.org/2001/XMLSchema#string

Scott Sloka

http://www.w3.org/2001/XMLSchema#string

Wolfgang Brück

http://www.w3.org/2001/XMLSchema#string

Yan Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

Mechanisms underlying inflammation in neurodegeneration

Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia.

PKCdelta mediates Nrf2-dependent protection of neuronal cells from NO-induced apoptosis.

The myeloid cells of the central nervous system parenchyma.

Placebo-controlled trial of oral laquinimod for multiple sclerosis.

Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons.

MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway.

P304

409-422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACN3.67

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Manoj Kumar Mishra

P577

2014-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261831607

http://www.w3.org/2001/XMLSchema#string

P698

25356411

http://www.w3.org/2001/XMLSchema#string

P921

microglial inhibitor

P932

4184669

http://www.w3.org/2001/XMLSchema#string